scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1365-2141.1991.TB07941.X |
P698 | PubMed publication ID | 1998597 |
P2093 | author name string | Grant S | |
Pettit GR | |||
Howe C | |||
McCrady CW | |||
Staniswalis J | |||
P2860 | cites work | Studies and perspectives of protein kinase C. | Q34162282 |
Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells | Q34371859 | ||
Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin | Q34691345 | ||
Studies of a human T lymphocyte antigen recognized by a monoclonal antibody. | Q35331561 | ||
Tumor-promoting phorbol esters stimulate myelopoiesis and suppress erythropoiesis in cultures of mouse bone marrow cells | Q35403698 | ||
Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. | Q35592713 | ||
Tumor promoters enhance myeloid and erythroid colony formation by normal mouse hemopoietic cells | Q36398238 | ||
Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents | Q37320906 | ||
The human hematopoietic colony-stimulating factors | Q39656937 | ||
The molecular control of blood cell development | Q39682109 | ||
Inositol trisphosphate and diacylglycerol as second messengers | Q40094697 | ||
Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide-dependent protein kinase and protein kinase C | Q42244464 | ||
Bryostatins: potent, new mitogens that mimic phorbol ester tumor promoters | Q42813898 | ||
Bryostatin, a non-phorbol macrocyclic lactone, activates intact human polymorphonuclear leukocytes and binds to the phorbol ester receptor | Q43765807 | ||
The biochemical basis of transmembrane signalling by B lymphocyte surface immunoglobulin | Q47688578 | ||
Isolation and structure of bryostatin 1 | Q57255655 | ||
Antineoplastic Components of Marine Animals | Q59090309 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | macrophage | Q184204 |
P304 | page(s) | 5-15 | |
P577 | publication date | 1991-01-01 | |
P1433 | published in | British Journal of Haematology | Q4970200 |
P1476 | title | Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSF. | |
P478 | volume | 77 |
Q34729529 | A phase I study of intravenous bryostatin 1 in patients with advanced cancer |
Q36081460 | A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion. |
Q30969641 | Marine-derived anticancer agents in clinical trials |
Q35733482 | Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant. |
Q36081455 | Review of survival analyses published in cancer journals |
Q77352762 | The inhibitory effects of bryostatin 1 administration on the growth of rabbit papillomas |
Q45080764 | Variable effects of tamoxifen on human hematopoietic progenitor cell growth and sensitivity to doxorubicin |